These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 22472445)

  • 21. Improved processability of ethambutol hydrochloride by spherical agglomeration.
    Nitsure A; Patel D; Wairkar S
    Pharm Dev Technol; 2020 Mar; 25(3):376-384. PubMed ID: 31842656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Co-proccessed excipients with enhanced direct compression functionality for improved tableting performance.
    Rojas J; Buckner I; Kumar V
    Drug Dev Ind Pharm; 2012 Oct; 38(10):1159-70. PubMed ID: 22966909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications.
    Kawabata Y; Wada K; Nakatani M; Yamada S; Onoue S
    Int J Pharm; 2011 Nov; 420(1):1-10. PubMed ID: 21884771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of spherical iron(II) sulfate heptahydrate-containing solid particles with sustained drug release.
    Szabó-Révész P; Farkas B; Gregor T; Nagy K; Pallagi E
    Eur J Pharm Biopharm; 2007 May; 66(2):193-9. PubMed ID: 17125982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of coning phenomena for irregular particles in paddle dissolution test.
    Higuchi M; Nishida S; Yoshihashi Y; Tarada K; Sugano K
    Eur J Pharm Sci; 2015 Aug; 76():213-6. PubMed ID: 25998150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Towards a better understanding of the role of stabilizers in QESD crystallizations.
    Hansen J; Kleinebudde P
    Pharm Res; 2022 Dec; 39(12):3123-3136. PubMed ID: 35266086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Agglomeration of celecoxib by quasi-emulsion solvent diffusion method without stabilizer: effect of good solvent.
    Maghsoodi M; Nokhodchi A
    Pharm Dev Technol; 2018 Dec; 23(10):1037-1046. PubMed ID: 27937049
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Definition of a solvent system for spherical crystallization of salbutamol sulfate by quasi-emulsion solvent diffusion (QESD) method.
    Nocent M; Bertocchi L; Espitalier F; Baron M; Couarraze G
    J Pharm Sci; 2001 Oct; 90(10):1620-7. PubMed ID: 11745720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An investigation into the effect of formulation variables and process parameters on characteristics of granules obtained by in situ fluidized hot melt granulation.
    Mašić I; Ilić I; Dreu R; Ibrić S; Parojčić J; Durić Z
    Int J Pharm; 2012 Feb; 423(2):202-12. PubMed ID: 22197773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Study of the preparation of sustained-release microspheres containing zedoary turmeric oil by the emulsion-solvent-diffusion method and evaluation of the self-emulsification and bioavailability of the oil.
    You J; Cui FD; Han X; Wang YS; Yang L; Yu YW; Li QP
    Colloids Surf B Biointerfaces; 2006 Mar; 48(1):35-41. PubMed ID: 16480856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of laminar extrudates manufactured at room temperature in the absence of solvents for the delivery of drugs.
    Oliveira G; Wahl MA; Pinto JF
    Int J Pharm; 2013 Sep; 454(1):90-8. PubMed ID: 23845856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Particle design of poorly water-soluble drug substances using supercritical fluid technologies.
    Yasuji T; Takeuchi H; Kawashima Y
    Adv Drug Deliv Rev; 2008 Feb; 60(3):388-98. PubMed ID: 18068261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In situ controlled crystallization as a tool to improve the dissolution of Glibenclamide.
    Elkordy AA; Jatto A; Essa E
    Int J Pharm; 2012 May; 428(1-2):118-20. PubMed ID: 22426322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simultaneous micronization and surface modification for improvement of flow and dissolution of drug particles.
    Han X; Ghoroi C; To D; Chen Y; Davé R
    Int J Pharm; 2011 Aug; 415(1-2):185-95. PubMed ID: 21664954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spray-dried nanofibrillar cellulose microparticles for sustained drug release.
    Kolakovic R; Laaksonen T; Peltonen L; Laukkanen A; Hirvonen J
    Int J Pharm; 2012 Jul; 430(1-2):47-55. PubMed ID: 22465549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improved compressibility, flowability, dissolution and bioavailability of pioglitazone hydrochloride by emulsion solvent diffusion with additives.
    Patil SV; Pawar AP; Sahoo SK
    Pharmazie; 2012 Mar; 67(3):215-23. PubMed ID: 22530302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Challenges in the development of hydrate phases as active pharmaceutical ingredients--an example.
    Feth MP; Nagel N; Baumgartner B; Bröckelmann M; Rigal D; Otto B; Spitzenberg M; Schulz M; Becker B; Fischer F; Petzoldt C
    Eur J Pharm Sci; 2011 Jan; 42(1-2):116-29. PubMed ID: 21073949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Particle engineering of benzoic acid by spherical agglomeration.
    Thati J; Rasmuson ÅC
    Eur J Pharm Sci; 2012 Apr; 45(5):657-67. PubMed ID: 22266212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spherical crystallization: A technique use to reform solubility and flow property of active pharmaceutical ingredients.
    Chatterjee A; Gupta MM; Srivastava B
    Int J Pharm Investig; 2017; 7(1):4-9. PubMed ID: 28405573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Centrifugal air-assisted melt agglomeration for fast-release "granulet" design.
    Wong TW; Musa N
    Int J Pharm; 2012 Jul; 430(1-2):184-96. PubMed ID: 22531845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.